Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of methotrexate, mechlorethamine,
vincristine, procarbazine, and prednisone in treating children with astrocytomas or primitive
neuroectodermal tumors.